Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Metabolomics data for Matrix pipeline validation QE data High biomass samples

ABSTRACT: Metabolomics data collected for high biomass fecal and saliva samples on quadrupole-Orbitrap mass spectrometer to validate a standardized method for sample accession, DNA and metabolite extraction using single tubes (Matrix tubes).

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Pieter C Dorrestein

PROVIDER: MSV000090544 | MassIVE | Mon Oct 17 23:17:00 BST 2022

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Similar Datasets

GNPS - Metabolomics data for Matrix pipeline validation QE data High biomass samples

Project description:Metabolomics data collected for high biomass fecal and saliva samples on quadrupole-Orbitrap mass spectrometer to validate a standardized method for sample accession, DNA and metabolite extraction using single tubes (Matrix tubes).

2022-10-17 | MSV000090544 | GNPS

Metabolomics data for Matrix pipeline validation

Project description:Metabolomics data for validation of the matrix pipeline.

2022-08-04 | MSV000090083 | MassIVE

GNPS - Metabolomics data for Matrix pipeline validation

Project description:Metabolomics data for validation of the matrix pipeline.

2022-08-04 | MSV000090083 | GNPS

Characteristics of Human and Microbiome RNA Profiles in Saliva

Project description:Saliva is a convenient non-invasive source of liquid biopsy to monitor human health and diagnose diseases. In particular, extracellular vesicles (EVs) in saliva can potentially reveal clinically relevant information for systemic health. Recent studies have shown that RNA in saliva EVs could be exploited as biomarkers for disease diagnosis. However, there is no standardized protocol for profiling RNA in saliva EV nor clear guideline on selecting saliva fractions for biomarker analysis. To address these issues, we established a robust protocol for small RNA profiling from fractionated saliva. With this method, we performed comprehensive small RNA sequencing of four saliva fractions, including cell-free saliva (CFS), EV-depleted saliva (EV-D), exosome (EXO), and microvesicle (MV) from ten healthy volunteers. Methods: To address these issues, we established a robust protocol for small RNA profiling from fractionated saliva. With this method, we performed comprehensive small RNA sequencing of four saliva fractions, including cell-free saliva (CFS), EV-depleted saliva (EV-D), exosome (EXO), and microvesicle (MV) from ten healthy volunteers.

2023-01-07 | GSE222014 | GEO

Implementing an X-ray validation pipeline for the Protein Data Bank.

Project description: Not available

| S-EPMC3322607 | biostudies-literature

INKA, an integrative analysis pipeline for inference of hyperactive phosphokinases in mass spectrometry-based phosphoproteomics data

Project description:this data upload is part of PXD006616. The new data is acquired from human-in-mouse PDX tumor tissue. The data uploaded as PXD006616 was cell line data. The two data sets can be merged into a single PXD accession. The Sample processing and Data processing sections are updated and the corresponding sections in PXD006616 can be replaced by the new sections.

2019-04-18 | PXD009995 | Pride

Validation data for Lawrence Livermore Microbial Detection Array version 2

Project description:We designed a pan-Microbial Detection Array (MDA) to detect all known viruses (including phage), bacteria, and plasmids. Family-specific probes were selected for all sequenced viral and bacterial complete genomes, segments, and plasmids. Probes were designed to tolerate some sequence variation to enable detection of divergent species with homology to sequenced organisms. The array has wider coverage of bacterial and viral targets based on more recent sequence data and more probes per target than other microbial detection/discovery arrays in the literature. In blinded lab testing on spiked samples with single or multiple viruses, the MDA was able to correctly identify species or strains. In clinical fecal, serum, and respiratory samples, the MDA was able to detect and characterize multiple viruses, phage, and bacteria in a sample to the family and species level, as confirmed by PCR. Testing of microbial detection array with mixtures of known viruses, blinded clinical samples and viral cell culture samples.

2010-10-15 | E-GEOD-24626 | biostudies-arrayexpress

Validation data for Lawrence Livermore Microbial Detection Array version 1

2010-10-15 | E-GEOD-24699 | biostudies-arrayexpress

Validation data for Lawrence Livermore Microbial Detection Array version 1

2010-10-15 | GSE24699 | GEO

Validation data for Lawrence Livermore Microbial Detection Array version 2

2010-10-15 | GSE24626 | GEO